XTX Topco Ltd

Position in NVO — Novo Nordisk A S

CIK 1828301 LONDON, X0

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,321,254

+$463,219 QoQ

Shares Held

48,420

+32.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#353

of 1,348 holders

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $46,000,026 across 13 Drug Manufacturers - General names. NVO ranks #4 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	834,735	$20,100,418
2	GILD	Gilead Sciences, Inc.	68,150	$8,610,071
3	LLY	ELI LILLY & Co	6,991	$8,385,215
4	NVO	Novo Nordisk A S This page	48,420	$2,321,254
5	GSK	GSK plc	35,304	$1,850,635
6	NVS	Novartis AG	11,248	$1,762,786
7	JNJ	Johnson & Johnson	5,135	$1,304,135
8	BIIB	Biogen Inc.	3,239	$699,818

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,321,254	48,420	+32.6%	Shares	Defined	2026-08-14
2025-12-31	$1,858,035	36,518	+431.2%	Shares	Defined	2026-02-17
2025-09-30	$381,493	6,875	+11.9%	Shares	Defined	2025-11-14
2025-06-30	$424,058	6,144	-39.5%	Shares	Defined	2025-08-12
2025-03-31	$705,649	10,162	+65.8%	Shares	Defined	2025-05-08
2024-09-30	$729,780	6,129	-75.4%	Shares	Defined	2024-11-14
2024-06-30	$3,552,798	24,890	+464.7%	Shares	Defined	2024-08-12
2024-03-31	$565,987	4,408	-25.2%	Shares	Defined	2024-05-13
2023-12-31	$609,423	5,891	+158.8%	Shares	Defined	2024-02-13
2023-06-30	$368,325	2,276	-68.3%	Shares	Defined	2023-08-14
2022-12-31	$971,064	7,175	+199.5%	Shares	Defined	2023-02-14
2021-12-31	$268,352	2,396	-61.3%	Shares	Defined	2022-02-11
2021-09-30	$595,069	6,198	+7.4%	Shares	Defined	2021-11-12
2021-03-31	$389,148	5,772	—	Shares	Defined	2021-05-14
No filing history on record for this holder in this stock.